thalidomide has been researched along with canertinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, B; Liu, H; Qiu, X; Qu, X; Song, X; Sun, N; Yang, X; Zhong, H | 1 |
1 other study(ies) available for thalidomide and canertinib
| Article | Year |
|---|---|
Effective degradation of EGFR
Topics: Apoptosis; Autophagy; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Lysosomes; Molecular Structure; Morpholines; Mutation; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Structure-Activity Relationship; Thalidomide | 2021 |